Medicare patients with advanced cancers will now have access to a more 21st century diagnostic: gene-sequencing tests to match them with the right drugs.
Medicare patients with advanced cancers will now have access to a more 21st century diagnostic: gene-sequencing tests to match them with the right drugs.
This process would not only eliminate the need for perfect match donors, but it would dramatically reduce the chance of immunorejection. (via The Daily Beast)
